Cluster analysis and clinical asthma phenotypes
- PMID: 18480428
- PMCID: PMC3992366
- DOI: 10.1164/rccm.200711-1754OC
Cluster analysis and clinical asthma phenotypes
Abstract
Rationale: Heterogeneity in asthma expression is multidimensional, including variability in clinical, physiologic, and pathologic parameters. Classification requires consideration of these disparate domains in a unified model.
Objectives: To explore the application of a multivariate mathematical technique, k-means cluster analysis, for identifying distinct phenotypic groups.
Methods: We performed k-means cluster analysis in three independent asthma populations. Clusters of a population managed in primary care (n = 184) with predominantly mild to moderate disease, were compared with a refractory asthma population managed in secondary care (n = 187). We then compared differences in asthma outcomes (exacerbation frequency and change in corticosteroid dose at 12 mo) between clusters in a third population of 68 subjects with predominantly refractory asthma, clustered at entry into a randomized trial comparing a strategy of minimizing eosinophilic inflammation (inflammation-guided strategy) with standard care.
Measurements and main results: Two clusters (early-onset atopic and obese, noneosinophilic) were common to both asthma populations. Two clusters characterized by marked discordance between symptom expression and eosinophilic airway inflammation (early-onset symptom predominant and late-onset inflammation predominant) were specific to refractory asthma. Inflammation-guided management was superior for both discordant subgroups leading to a reduction in exacerbation frequency in the inflammation-predominant cluster (3.53 [SD, 1.18] vs. 0.38 [SD, 0.13] exacerbation/patient/yr, P = 0.002) and a dose reduction of inhaled corticosteroid in the symptom-predominant cluster (mean difference, 1,829 mug beclomethasone equivalent/d [95% confidence interval, 307-3,349 mug]; P = 0.02).
Conclusions: Cluster analysis offers a novel multidimensional approach for identifying asthma phenotypes that exhibit differences in clinical response to treatment algorithms.
Figures

Similar articles
-
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.Am J Respir Crit Care Med. 2010 Feb 15;181(4):315-23. doi: 10.1164/rccm.200906-0896OC. Epub 2009 Nov 5. Am J Respir Crit Care Med. 2010. PMID: 19892860 Free PMC article.
-
Evidence for 2 clusters among patients with noneosinophilic asthma.Ann Allergy Asthma Immunol. 2024 Jul;133(1):57-63.e4. doi: 10.1016/j.anai.2024.03.012. Epub 2024 Mar 16. Ann Allergy Asthma Immunol. 2024. PMID: 38499060
-
Identification of asthma phenotypes in a tertiary care medical center.Am J Med Sci. 2014 Dec;348(6):480-5. doi: 10.1097/MAJ.0000000000000346. Am J Med Sci. 2014. PMID: 25319436 Free PMC article.
-
Noneosinophilic asthma: a distinct clinical and pathologic phenotype.J Allergy Clin Immunol. 2007 May;119(5):1043-52; quiz 1053-4. doi: 10.1016/j.jaci.2007.02.042. J Allergy Clin Immunol. 2007. PMID: 17472810 Review.
-
How variability in clinical phenotypes should guide research into disease mechanisms in asthma.Ann Am Thorac Soc. 2013 Dec;10 Suppl(Suppl):S109-17. doi: 10.1513/AnnalsATS.201304-087AW. Ann Am Thorac Soc. 2013. PMID: 24313760 Free PMC article. Review.
Cited by
-
Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma.Respir Res. 2013 Feb 11;14(1):17. doi: 10.1186/1465-9921-14-17. Respir Res. 2013. PMID: 23398985 Free PMC article.
-
Assessment of murine lung mechanics outcome measures: alignment with those made in asthmatics.Front Physiol. 2013 Feb 12;3:491. doi: 10.3389/fphys.2012.00491. eCollection 2012. Front Physiol. 2013. PMID: 23408785 Free PMC article.
-
Clinical asthma phenotyping: A trial for bridging gaps in asthma management.World J Clin Pediatr. 2015 May 8;4(2):13-8. doi: 10.5409/wjcp.v4.i2.13. eCollection 2015 May 8. World J Clin Pediatr. 2015. PMID: 26015875 Free PMC article.
-
Integrative systems biology approaches in asthma pharmacogenomics.Pharmacogenomics. 2012 Sep;13(12):1387-404. doi: 10.2217/pgs.12.126. Pharmacogenomics. 2012. PMID: 22966888 Free PMC article. Review.
-
Personalised medicine and asthma diagnostics/management.Curr Allergy Asthma Rep. 2013 Feb;13(1):118-29. doi: 10.1007/s11882-012-0325-9. Curr Allergy Asthma Rep. 2013. PMID: 23212666 Review.
References
-
- Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet. 2006;368:780–793. - PubMed
-
- Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999;160:1001–1008. - PubMed
-
- Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R. Multidimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy. 2005;35:1254–1262. - PubMed
-
- Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006;368:804–813. - PubMed
-
- Heaney LG, Robinson DS. Severe asthma treatment: need for characterising patients. Lancet. 2005;365:974–976. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical